Dilemma for doctors as Roche ’s experimental drug for Covid-19 is ‘life-saver’ but too costly

In India, the drug sold under the brand name Actemra, is approved for the use in autoimmune disease such as rheumatoid arthritis and for six months treatment it costs Rs 2.5 lakh. For Covid-19 patients who are administered this drug, the cost is Rs 60,000 per dosage.
Source: The Economic Times - Category: Consumer Health News Source Type: news